Functional imaging of tumor proteolysis.
暂无分享,去创建一个
Bonnie F. Sloane | Dora Cavallo-Medved | K. Moin | M. Sameni | D. Cavallo-Medved | Mansoureh Sameni | Kamiar Moin | I. Podgorski | Bonnie F Sloane | Izabela Podgorski
[1] Bonnie F. Sloane,et al. Cathepsin B: association with plasma membrane in metastatic tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[2] X. Puente,et al. Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.
[3] Bonnie F. Sloane,et al. Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[4] A. Köhler,et al. Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[5] Y. DeClerck. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. , 2000, European journal of cancer.
[6] X. Puente,et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.
[7] E. Bröcker,et al. Release of cell fragments by invading melanoma cells. , 2004, European journal of cell biology.
[8] C. López-Otín,et al. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. , 2004, The International journal of developmental biology.
[9] P. Richardson,et al. Proteasome inhibition as a novel therapeutic target in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Bonnie F. Sloane,et al. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. , 1994, The American journal of pathology.
[11] James P. Quigley,et al. Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer , 2003, Cancer and Metastasis Reviews.
[12] R. Weinberg,et al. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.
[13] E. Sahai,et al. Integrin β1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo , 2004, British Journal of Cancer.
[14] Bonnie F. Sloane,et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. , 1994, The American journal of pathology.
[15] Bonnie F. Sloane,et al. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.
[16] S. Leppla,et al. Potent antitumor activity of a urokinase-activated engineered anthrax toxin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Khokha,et al. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development , 2003, British Journal of Cancer.
[18] Bonnie F. Sloane,et al. Imaging Proteolysis by Living Human Glioma Cells , 2001, Biological chemistry.
[19] K. Danø,et al. Stromal cell expression of components of matrix-degrading protease systems in human cancer. , 1996, Enzyme & protein.
[20] V. Giranda,et al. The protease consortium: An alliance to advance the understanding of proteolytic enzymes as therapeutic targets for cancer , 1999, Molecular Carcinogenesis.
[21] D. Cunningham,et al. Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies. , 2003, Critical reviews in oncology/hematology.
[22] L. Matrisian,et al. Molecular imaging of proteolytic activity in cancer , 2003, Journal of cellular biochemistry.
[23] Ralph Weissleder,et al. Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.
[24] Kinneret Keren,et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.
[25] L. Lund,et al. Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.
[26] Jeffrey W. Smith,et al. A Unique Substrate Recognition Profile for Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.
[27] M. Noguchi,et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. , 1999, Cancer research.
[28] C. Overall,et al. Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.
[29] Bonnie F. Sloane,et al. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. , 1994, Journal of cell science.
[30] Peter Friedl,et al. Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.
[31] Bonnie F. Sloane,et al. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. , 2003, Molecular imaging.
[32] R. Weissleder,et al. Optical zymography for specific detection of urokinase plasminogen activator activity in biological samples. , 2005, Analytical biochemistry.
[33] B. Nielsen,et al. Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[34] Erik Sahai,et al. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.
[35] Erik Sahai,et al. Mechanisms of cancer cell invasion. , 2005, Current opinion in genetics & development.
[36] Ralph Weissleder,et al. Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment. , 2002, Neoplasia.
[37] Carlos López-Otín,et al. Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.
[38] Ralph Weissleder,et al. Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter. , 2004, Chemistry & biology.
[39] J. Brugge,et al. Use of Three-Dimensional Basement Membrane Cultures to Model Oncogene-Induced Changes in Mammary Epithelial Morphogenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.
[40] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[41] Bonnie F. Sloane,et al. Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix. , 2000, Experimental cell research.
[42] D. Corey,et al. Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase* , 1997, The Journal of Biological Chemistry.
[43] Bonnie F. Sloane,et al. Cathepsin B and D are localized at the surface of human breast cancer cells , 2008, Pathology & Oncology Research.
[44] M. Bernardo,et al. Regulation of membrane type-matrix metalloproteinases. , 2002, Seminars in cancer biology.
[45] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[46] Vijaya Iragavarapu-Charyulu,et al. T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe? , 2004, Breast disease.
[47] J. Parsons,et al. Local degradation of fibronectin at sites of expression of the transforming gene product pp60src , 1985, Nature.
[48] Bonnie F. Sloane,et al. Cysteine cathepsins in human cancer , 2004, Biological chemistry.
[49] Bonnie F. Sloane,et al. Imaging proteolysis by living human breast cancer cells. , 2000, Neoplasia.
[50] Bonnie F. Sloane,et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. , 2005, Seminars in cancer biology.
[51] Matthew Bogyo,et al. Activity-based probes that target diverse cysteine protease families , 2005, Nature chemical biology.
[52] Bonnie F. Sloane,et al. Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells* , 2000, The Journal of Biological Chemistry.
[53] J. Saurat,et al. Differential protease expression by cutaneous squamous and basal cell carcinomas. , 1991, The Journal of clinical investigation.
[54] D. Corey,et al. Distinguishing the Specificities of Closely Related Proteases , 1997, The Journal of Biological Chemistry.
[55] Mina J Bissell,et al. Modeling tissue-specific signaling and organ function in three dimensions , 2003, Journal of Cell Science.
[56] L. Matrisian,et al. Tumor progression: Defining the soil round the tumor seed , 2001, Current Biology.
[57] Shiva Gautam,et al. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. , 2004, The Biochemical journal.
[58] Bonnie F. Sloane,et al. Degradation of laminin by human tumor cathepsin B , 1989, Clinical & Experimental Metastasis.
[59] Ralph Weissleder,et al. Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.
[60] N. Behrendt. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/ Endo180): membrane proteins engaged in matrix turnover during tissue remodeling , 2004, Biological chemistry.
[61] S Toba,et al. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. , 2000, Chemistry & biology.
[62] R. Smith,et al. Use of different derivatives ofd-Val-Leu-Arg for studying kallikrein activities in cat submandibular glands and saliva , 1985, The Histochemical Journal.
[63] D. Hanahan,et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.
[64] Bonnie F. Sloane. Suicidal tumor proteases , 1996, Nature Biotechnology.
[65] B. Nielsen,et al. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy , 2005, The Journal of cell biology.
[66] Smith Re,et al. The use of amino acid derivatives of 4-methoxy-beta-naphthylamine for the assay and subcellular localization of tissue proteinases. , 1975 .
[67] C. Blobel,et al. ADAMs: key components in EGFR signalling and development , 2005, Nature Reviews Molecular Cell Biology.
[68] G. Giannelli,et al. Cancer Invasion: Watch Your Neighbourhood! , 2003, Tumori.
[69] S. Leppla,et al. Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin* , 2001, The Journal of Biological Chemistry.
[70] Bonnie F. Sloane,et al. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles , 1983, Clinical & Experimental Metastasis.
[71] Bonnie F. Sloane,et al. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. , 1992, The Biochemical journal.
[72] Bonnie F. Sloane,et al. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. , 2005, Neoplasia.
[73] M. Stack,et al. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[74] P. Friedl,et al. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. , 2003, Biochemical Society symposium.
[75] Bonnie F. Sloane,et al. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells , 2005, Journal of Cell Science.
[76] Peter Friedl,et al. Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.